Sacral neuromodulation: Rechargeable versus non-rechargeable device. What would the patient preferences be in France?

X. Gamé (1) , A. Ruffion (2) , J.-N. Cornu (3, 4, 5, 6) , V. Phé (7) , B. Peyronnet (8) , M.-A. Perrouin-Verbe (9) , C. Aublant (10) , A. Adé (11) , E. Chartier-Kastler (7)

1 Département d'Urologie-Andrologie et Transplantation Rénale [CHU Toulouse]
2 Service d'urologie [Centre Hospitalier Lyon Sud - HCL]
3 ADEN - Nutrition, Inflammation et axe Microbiote-Intestin-Cerveau
4 IRIB - Institute for Research and Innovation in Biomedicine
5 UNIROUEN UFR Santé - UNIROUEN - UFR Santé
6 Service d'urologie [Rouen]
7 AP-HP - Assistance publique - Hôpitaux de Paris (AP-HP)
8 Service d'urologie [Rennes] = Urology [Rennes]
9 Service d'Urologie [Nantes]
10 Neuromodulation, neurovascular & pelvic healths, Medtronic France, Paris,
11 Health economics & reimbursement, Medtronic France, Paris

Domaines: Physiologie [q-bio.TO]

X. Gamé, A. Ruffion, J.-N. Cornu, V. Phé, B. Peyronnet, et al.. Sacral neuromodulation: Rechargeable versus non-rechargeable device. What would the patient preferences be in France?. Progrès en Urologie, 2022, ⟨10.1016/j.purol.2022.04.011⟩. ⟨hal-03714544⟩